Tumours of the Urinary System (Prostate + Testicular Cancer) Flashcards
What is the commonest cancer diagnosed in men?
Prostate
5 aetiologies/risk factors for prostate cancer?
- Age
- Race/ethnicity - African or Afro-Caribbean men living in Western countries vs East Asian or Asian men living in Western countries
- Geography - Northwestern Europe/Nort America/Caribbean/Australia vs Asia/Africa/Central + South America
- Family history - first degree relative 2x risk; HPC1; BRCA1 + 2
- Food (only probable) - selenium, lycopenes/carotenoids, vit E, omega 3 FA
- Drugs - Finasteride
Review of McNeal’s prostatic zones
Transition zone
Central zone
Peripheral zone
Anterior fibromuscular stroma

Where does prostate cancer most commonly arise?
Peripheral zone
What do most prostate cancers present as clinically?
Asymptomatic
How is prostate cancer diagnosed?
Through opportunistic PSA testing (not screening!)
What is the diagnostic triad of prostate cancer?
PSA (prostate-specific antigen)
Digital rectal examination
TRUS-guided prostate biopsy
What is PSA?
Prostate-specific antigen
(not necessarily cancer specific!)
Give presenting symptoms of local disease in prostate cancer?
- Weak stream*
- Hesitancy*
- Sensation of incomplete emptying*
- Frequency*
- Urgency*
- Urge incontinence*
- UTI*
Give presenting symptoms of locally invasive disease in prostate cancer?
Haematuria
Perineal adn suprapubic pain
Impotence
Incontinence
Loin pain or anuria resulting from obstruction of the ureters
Symptoms of renal failure
Heamospermia
Rectal symptoms inc tenesmus
What percentage of newly diagnosed prostate cancers are localised?
80%
Give presenting features of DISTANT METASTASES in prostate cancer
- Bone pain/sciatica
- Paraplegia secondary to spinal cord compression
- Llymph node enlargement
- Lymphoedema, particularly in the lower limbs
- Loin pain or anuria due to obstruction of the ureters by lymph nodes
Give the presenting symptoms of WIDESPREAD METASTASES in prostate cancer
- Lethargy (e.g. due to anaemia, uraemia)
- Weight loss and cachexia
MCQ - what is the commonest mode of presentation for prostate cancer?
Asymptomatic
Why is prostate cancer not screened for?
Wilson-Junger criteria not met
Level 1 evidence (i.e. RCTs and meta-analysis) that screening does not imprive cancer-specific mortality (compared with standard practice)
Screening leads to over-diagnosis and over-treatment of harmless cancers
How to avoid under treatment of aggressive cancers?
Ad-hoc PSA testing !!
What does Kllikrein serine protease (prostate-specific protein) do? What is it produced by?
Liquifies semen
The prostate glands - may leak into serum
What is the normal serum range for PSA?
Normal serum range 0-4.0ug/mL
How do PSA levels change with age? Give the age-related ranges
Increase with age
<50 yrs: 2.5 is upper limit
50-60 yrs: 3.5 is upper limit
60-70 yrs: 4.5 is upper limit
>70 yrs: 6.5 is upper limit
Other than BPH and prostate cancer, what else can cause PSA elevations?
UTI
Chronic prostatitis
Instrumentation (e.g. catheterisation)
Physiological (e.g. ejaculation)
Recent urological procedure
What is the half-life of PSA?
If a repeat PSA is needed, when should recheck be done?
2.2 days
Recheck in at least 3 weeks
Levels of PSA and cancer probability (PPV):
0-1.0: 5%
- 0-2.5: 15%
- 5–4.0: 25%
- 0-10: 40%
>10: 70%
How is prostate cancer graded?
Gleason Grading
Score 3-5 (well to poorly differetiated)
Then summated to give Gleason SUM score e.g. 3 + 4 = 7 (3 being most common/biggest area; 4 being second most common when looking at cells)
Useful prognostically to determine aggressiveness of cancer - guides treatment
What is the gleason sum score now being changed to?
ISUP grade group
3+3 = 6 -> 1
3+4 = 7 -> 2
4+3 = 7 -> 3
8 = 4
9 and 10 = 5
(2 is better prognosis than 3 because bigger area of 3)
Give the 4 stages that prostate cancer is divided into for treatment and prognosis
- Localised*
- Locally advanced*
- Metastatic*
- Hormone refractory*
How is localised prostate cancer staged? (what investigations)
Digital rectal examination (local staging)
PSA
Transrectal US guided biopsies
CT (regional and distant staging)
MRI (local staging)
Staging of localized prostate cancer by DRE
T2b more than 50% of one lobe compared to T2a which is less than 50%
T4 adjacent organs often the bladder or rectum

Give the 3 methods for treatment of localised prostate cancer
- Watchful waiting
- Radiotherapy: external-beam, brachytherapy
- Radical prostatectomy: open, laparoscopic, robotic
(others under inv = cryotherapy, thermotherapy)
Give the 5 methods of treatment for locally advanced prostate cancer
- Watchful waiting
- Hormone therapy follwoed by surgery
- Hormone therpay followed by radiation
- Hormone therapy alone
- Intermitted hormone therapy (clinical research)
Give the 4 types of hormonal therapy for prostate cancer
- Surgical castration (i.e. bilateral orchidectomy)
- Chemical castration (i.e. LHRH analogue - goserlin, leuprorelin (causes tumour flare in first week - need anti-androgen); or LNRH antagonists) (acts on pituitary stops ADH going to testis to make testosterone)
- Anti-androgens - inhibits androgen receptors on the testis
- Oestrogens (i.e. diethylstilboestrol) - inhibits LHRH and testosterone secretion, inactivates androgens and has direct cytotoxic effect on prostatic epithelial cells
Give the complications of metastatic and hormone refractory prostate cancer
- Bone: pain, pathological fractures, anaemia, spinal cord compression
- Rectal: constipation, bowel obstruction
- Ureteric: obstruction resulting in renal failure
- Pelvic lymphatic obstruction: lymphoedema, DVT
- Lower UTI: haematuria, acute retention
What is the mainstay of treatment for metastatic and hormone refractory prostate cancer?
Immediate hormonal therapy
What is the supportive treatment for metastatic and hormone refractory prostate cancer?
Palliaitive radiotherapy to bony metastases, colostomy, nephrostomy, zoledronic acid, palliative care support
When will hormone refractory stage be reached in metastatic prostate cancer?
In 18-24 months of treatment
–Diethylstilboestrol can be tried (high risk of thromboembolic and cardiovascular complications); median response time 4 months
–Docetaxel has survival benefit of 3 months
–Median survival of HRPC stage is 10 months
Summary treatment of localised disease

Stages and prognosis of prostate cancer
